Story perspectives

Study Reveals Psychiatric Distress Common with Psychedelics

1/16/2026

50 5

Summary

Story summary

A study in Psychiatry Research analyzed global pharmacovigilance data on classic psychedelics and MDMA, finding psychiatric distress is common and severe physical issues are rare.
The World Health Organization's VigiBase pharmacovigilance database shows 1,573 adverse reports for MDMA and 394 for LSD, with psychiatric disorders the most frequent.
Limitations include underreporting and lack of detailed patient data, underscoring the need for further real-world research.

1 of 1

Story summary

A study in Psychiatry Research analyzed global pharmacovigilance data on classic psychedelics and MDMA, finding psychiatric distress is common and severe physical issues are rare.
The World Health Organization's VigiBase pharmacovigilance database shows 1,573 adverse reports for MDMA and 394 for LSD, with psychiatric disorders the most frequent.
Limitations include underreporting and lack of detailed patient data, underscoring the need for further real-world research.